"Clarity Clinical Research is a private research facility working to improve health and medicine through clinical trials. We work closely with various community partners and our wonderful research volunteers as we fight some of the world's most devastating diseases, like Alzheimer's disease."

During the past decade, Velocity Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Velocity Clinical Research" #1 sponsor was "Eli Lilly and Company" with 2 trials, followed by "ModernaTX, Inc." with 2 trials sponsored, "GAP Innovations, PBC" with 1 trials sponsored, "Hoffmann-La Roche" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Velocity Clinical Research" #1 collaborator was "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator, "National Institute on Aging (NIA)" with 1 trials as a collaborator and "Vanderbilt University" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Velocity Clinical Research" are "Alzheimer Disease" (3 trials), "Mild Cognitive Impairment" (2 trials), "Alzheimer Disease, Early Onset" (1 trials), "Alzheimers Disease" (1 trials) and "Cognitive Dysfunction" (1 trials). Many other conditions were trialed in "Velocity Clinical Research" in a lesser frequency.

Most popular intervention types in "Velocity Clinical Research" are "Drug" (5 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Active Comparator: Licensed IIV IIV will be administered as a single dose intramuscularly on Day 1" (1 trials), "Biomarker Data Collection" (1 trials), "Donanemab" (1 trials) and "Experimental: IIV-A Investigational IIV-A will be administered as a single dose intramuscularly on Day 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Velocity Clinical Research" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Velocity Clinical Research". undefined are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Velocity Clinical Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Velocity Clinical Research, 1 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".